Beam Therapeutics (BEAM) Earnings Date & Reports

A.I. Advisor

published Earnings

BEAM is expected to report earnings to rise 3.60% to -114 cents per share on November 04

Beam Therapeutics BEAM Stock Earnings Reports

Q3'24

Est.

$-1.15

Q2'24

Beat

by $0.02

Q1'24

Beat

by $0.20

Q4'23

Beat

by $2.42

Q3'23

Beat

by $0.11

The last earnings report on August 06 showed earnings per share of -111 cents, beating the estimate of -112 cents. With 654.14K shares outstanding, the current market capitalization sits at 2.06B.

View a ticker or compare two or three

Compare

BEAM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For BEAM
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for BEAM (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a company, which develops and commercializes DNA base editing technologies for the treatment of human disease.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

238 Main Street

Phone

+1 857 327-8775

Employees

436

Web

https://www.beamtx.com